Pulmonary berylliosis on corticosteroid therapy, with cavitating lung lesions and aspergillomata-report on a fatal case

9Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A fatal case of pulmonary berylliosis in a 42 year old male is described. The patient was exposed to beryllium while working in a chemical plant over a 9 year period, and presented two years after ceasing such employment. The berylliosis was diagnosed on open lung biopsy in 1971. The patient was commenced on steroid therapy at that time. He suffered progressive dyspnoea from severe restrictive lung disease over the next 14 years. A chest X-ray ofJune 1985 revealed a lesion in the left upper lobe suggestive of a mycetoma. Before any therapy could be instituted he suffered a massive haemoptysis and died. Postmortem examination revealed two large mycetomata in the right and left upper lobes. Parenchymal histology showed evidence of chronic inflammation with non-caseating granulomata and the cavity wall showed localized invasion by Aspergillusfumigatus. It is possible that the long term steroid therapy with multiple boosters of treatment may have contributed to the development of the mycetoma. This is the first case report known to the authors of a fatal aspergilloma in association with chronic berylliosis treated with steroids. © The Fellowship of Postgraduate Medicine, 1987.

Cite

CITATION STYLE

APA

O’Brien, A. A. J., Moore, D. P., & Keogh, J. A. B. (1987). Pulmonary berylliosis on corticosteroid therapy, with cavitating lung lesions and aspergillomata-report on a fatal case. Postgraduate Medical Journal, 63(743), 797–799. https://doi.org/10.1136/pgmj.63.743.797

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free